The new cGMP-compliant HPAPI Laboratory is equipped with state-of-the-art isolators designed to meet Occupational Exposure Band 5 (OEB-5) requirements
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
This strategic investment strengthens Cohance's integrated oligonucleotide platform
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Reported EBITDA up by 19% year-on-year with reported EBITDA margin at 25%
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Subscribe To Our Newsletter & Stay Updated
